Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$510M |
| 2 |
Pfizer
PFE
|
+$265M |
| 3 |
Gilead Sciences
GILD
|
+$212M |
| 4 |
Comcast
CMCSA
|
+$191M |
| 5 |
Meta Platforms (Facebook)
META
|
+$184M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class C
GOOG
|
+$369M |
| 2 |
SIAL
SIGMA - ALDRICH CORP
SIAL
|
+$330M |
| 3 |
MJN
Mead Johnson Nutrition Company
MJN
|
+$230M |
| 4 |
Amgen
AMGN
|
+$223M |
| 5 |
Teva Pharmaceuticals
TEVA
|
+$145M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.46% |
| 2 | Healthcare | 12.72% |
| 3 | Financials | 10.51% |
| 4 | Industrials | 9.69% |
| 5 | Consumer Staples | 9.42% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
PCH
326
DELISTED
PotlatchDeltic
PCH
| $32.8M | 0.07% |
1,083,216
+75,463
| +7% | +$2.36M |
|
|
MBLY
327
DELISTED
Mobileye N.V.
MBLY
| $32.7M | 0.07% |
774,400
+514,000
| +197% | +$23M |
|
|
DFT
328
DELISTED
DuPont Fabros Technology Inc.
DFT
| $32.7M | 0.07% |
1,027,400
-793
| -0.1% | -$24.7K |
|
329
PACCAR
PCAR
$72.7B
| $32.5M | 0.07% |
1,027,317
+425,400
| +71% | +$14.5M |
|
|
BRCM
330
DELISTED
BROADCOM CORP CL-A
BRCM
| $32.5M | 0.07% |
561,357
+144,565
| +35% | +$7.78M |
|
331
National Beverage
FIZZ
$3.05B
| $32.4M | 0.07% |
1,426,400
+107,400
| +8% | +$2.08M |
|
|
DEG
332
DELISTED
ETABLISSEMENT DELHZ ADS 4 ADS REPTGS 1 ORD SHS
DEG
| $32.4M | 0.07% |
1,333,200
+127,200
| +11% | +$3.02M |
|
|
VIVO
333
DELISTED
Meridian Bioscience Inc
VIVO
| $32.3M | 0.07% |
1,574,576
+183,321
| +13% | +$3.51M |
|
|
PAY
334
DELISTED
Verifone Systems Inc
PAY
| $32.2M | 0.07% |
1,150,919
+643,400
| +127% | +$18.6M |
|
335
WSFS Financial
WSFS
$4.2B
| $32.1M | 0.07% |
993,405
+76,305
| +8% | +$2.44M |
|
336
Consolidated Edison
ED
$41.3B
| $31.8M | 0.07% |
494,700
+21,300
| +4% | +$1.37M |
|
337
Vornado Realty Trust
VNO
$7.54B
| $31.8M | 0.07% |
393,242
-843,509
| -68% | -$66.5M |
|
|
RDS.A
338
DELISTED
Royal Dutch Shell PLC ADS Class A
RDS.A
| $31.7M | 0.07% |
692,937
-285,357
| -29% | -$14.3M |
|
339
Evercore
EVR
$13.2B
| $31.6M | 0.07% |
584,400
+109,500
| +23% | +$5.91M |
|
340
Brown-Forman Class B
BF.B
$13.3B
| $31.6M | 0.07% |
994,297
+921,094
| +1,258% | +$30.7M |
|
341
International Paper
IP
$23.3B
| $31.6M | 0.07% |
884,189
-357,559
| -29% | -$13.8M |
|
|
CY
342
DELISTED
Cypress Semiconductor
CY
| $31.5M | 0.07% |
3,210,259
+327,100
| +11% | +$3.25M |
|
343
Cintas
CTAS
$86B
| $31.4M | 0.07% |
1,380,272
+1,141,600
| +478% | +$26M |
|
|
PRMW
344
DELISTED
Primo Water Corporation
PRMW
| $31.4M | 0.07% |
2,855,800
+116,300
| +4% | +$1.22M |
|
345
Cheesecake Factory
CAKE
$4.42B
| $31.3M | 0.07% |
678,445
+341,645
| +101% | +$16.7M |
|
346
LyondellBasell Industries
LYB
$18.8B
| $31.2M | 0.07% |
359,400
-269,700
| -43% | -$24.8M |
|
347
Assurant
AIZ
$14B
| $31.2M | 0.07% |
387,685
+313,934
| +426% | +$25.9M |
|
348
West Pharmaceutical
WST
$23.7B
| $31M | 0.07% |
514,500
-84,000
| -14% | -$5.05M |
|
|
AEPI
349
DELISTED
AEP Industries Inc
AEPI
| $30.9M | 0.07% |
400,946
+83,546
| +26% | +$6.66M |
|
350
Carter's
CRI
$1.45B
| $30.8M | 0.07% |
345,600
+94,900
| +38% | +$8.47M |
|
Similar funds
Renaissance Technologies's Q4 2015 Portfolio in Review
As of Q4 2015, Renaissance Technologies held 3,639 positions worth $45.9B, up 9.5% from $41.9B the previous quarter. Its ten largest holdings account for 9.3% of the portfolio.
Renaissance Technologies deployed $3.07B of net new capital in Q4 2015, opening 509 new positions and adding to 1,872 existing holdings. Its largest new stake was Apple: 17,852,932 shares worth $470M.
By sector, the portfolio is most concentrated in Technology at 14% of assets, up from 11% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Alphabet (Google) Class C, an estimated $369M trimmed.
- Renaissance Technologies's largest Q4 2015 buy was Apple: 17,852,932 shares worth $470M.
- Renaissance Technologies added most to Gilead Sciences in Q4 2015, an estimated $212M increase.
- Renaissance Technologies's biggest Q4 2015 reduction was Alphabet (Google) Class C, cutting an estimated $369M.
- Renaissance Technologies fully exited SIGMA - ALDRICH CORP in Q4 2015, selling an estimated $330M.
- Renaissance Technologies's ten largest holdings make up 9.3% of its $45.9B portfolio in Q4 2015.
- Renaissance Technologies opened 509 new positions and closed 386 in Q4 2015.
- Renaissance Technologies's portfolio value rose 9.5% quarter-over-quarter to $45.9B.
Based on Renaissance Technologies's 13F filing for Q4 2015, filed 11 Feb 2016.